GlassScriptPhysician profile
Alice Lin
NPI 1477012441
$800.84
in general payments reported to CMS, 2019-2025
12 companies · $133 in 2025
The $133 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2021: $88.25 · 2022: $26.42 · 2023: $209 · 2024: $223 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $229.75 | 2019-2023 | Trelegy Ellipta |
| Corium, LLC | $119.00 | 2023-2025 | Azstarys |
| Pfizer INC. | $106.56 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $79.54 | 2024-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Cranial Technologies, INC | $64.82 | 2023-2025 | Doc Band |
| Sanofi Pasteur INC. | $50.47 | 2023 | |
| Sanofi-Aventis U.S. LLC | $41.69 | 2024 | |
| Mirum Pharmaceuticals, INC. | $23.88 | 2024 | Cholbam |
| Ironshore Pharmaceuticals INC. | $23.61 | 2024 | |
| Photonicare INC | $22.94 | 2025 | Otosight Middle Ear Scope |
| Lnhc, INC | $20.02 | 2025 | Zelsuvmi |
| Astrazeneca Pharmaceuticals LP | $18.56 | 2023 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.